Pradaxa® now available in UK for treatment of DVT and PE

Boehringer Ingelheim has announced that Pradaxa® will be commercially available in the UK for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of it's recurrence, from July 14th.

Source: Pharmacy Europe - July 15, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Cardiovascular medicine Haematology Latest News Source Type: news